NA 0345

Drug Profile

NA 0345

Latest Information Update: 06 Aug 1998

Price : $50

At a glance

  • Originator Nonindustrial source
  • Class Cardiotonics
  • Mechanism of Action Protein kinase C inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Heart failure

Most Recent Events

  • 06 Aug 1998 No-Development-Reported for Heart failure in Japan (Unknown route)
  • 20 Nov 1996 Preclinical development for Heart failure in Japan (Unknown route)
  • 10 Nov 1995 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top